HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

1,2-di(quinazolin-4-yl)diselane

has antineoplastic activity; structure in first source

Also Known As:

LG003 compound

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Quinazolines: 402
      - 1,2-di(quinazolin-4-yl)diselane: 1
Organic Chemicals: 133
- Organoselenium Compounds: 63
  - 1,2-di(quinazolin-4-yl)diselane: 1

Experts

1.	Fang, Qiang: 1 article (01/2017)
2.	Huang, Yinjiu: 1 article (01/2017)
3.	Liu, Xiaofen: 1 article (01/2017)
4.	Niu, Qun: 1 article (01/2017)
5.	Ru, Shuo: 1 article (01/2017)
6.	Shen, Lin: 1 article (01/2017)
7.	Tang, Bikui: 1 article (01/2017)
8.	Wei, Meili: 1 article (01/2017)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2017 - "In previous study, we found that 1,2-di(quinazolin-4-yl)diselane (DQYD), a quinazoline derivative, has anticancer activities against many cancers. "

Related Drugs and Biologics

1.	Quinazolines